Matt Devalaraja
- Nephrology top 10%
- Dialysis and Renal Disease Management 2
- Hematology top 10%
- Erythropoietin and Anemia Treatment 2
- Iron Metabolism and Disorders 2
-
- Sodium Intake and Health 1
-
- Adipokines, Inflammation, and Metabolic Diseases 1
-
- Health Systems, Economic Evaluations, Quality of Life 1
-
- Healthcare cost, quality, practices 1
-
- Birth, Development, and Health 1
- Co-authors
- Larry LoMichael DavidsonPablo E. PérgolaDouglas KlingPaul M. RidkerG. Kees HovinghDominic S. RajPeter Libby
- Cited by
- ImmunologyNephrologyHematology
- Journals
- Journal of the American Society of Nephrology (1 paper)Journal of Clinical Medicine (1 paper)Nephrology Dialysis Transplantation (1 paper)
- Partner nations
- United StatesItalyDenmark
In The Last Decade
Matt Devalaraja
7 papers receiving 535 citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Immunology 196
- Nephrology 61
- Hematology 75
- Cardiology and Cardiovascular Medicine 130
- Genetics 40
Countries citing papers authored by Matt Devalaraja
This map shows the geographic impact of Matt Devalaraja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Devalaraja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Devalaraja more than expected).
Fields of papers citing papers by Matt Devalaraja
This network shows the impact of papers produced by Matt Devalaraja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Devalaraja. The network helps show where Matt Devalaraja may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matt Devalaraja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 6 | |
| 3 | IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trialbreakdown → | 2021 | 433 |
| 4 | 2020 | 54 | |
| 5 | 2020 | 8 | |
| 6 | 2019 | 0 | |
| 7 | 2019 | 20 | |
| 8 | 2015 | 18 |
About Matt Devalaraja
Matt Devalaraja is a scholar working on Nephrology, Hematology, Immunology and Allergy, Dermatology and Immunology, having authored 8 papers that have together received 541 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (2 papers), Iron Metabolism and Disorders (2 papers), Dialysis and Renal Disease Management (2 papers), Sodium Intake and Health (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Healthcare cost, quality, practices (1 paper) and Birth, Development, and Health (1 paper). The work is most often cited by research in Immunology (196 citations), Nephrology (61 citations), Hematology (75 citations), Cardiology and Cardiovascular Medicine (130 citations) and Genetics (40 citations). Matt Devalaraja has collaborated with scholars based in United States, Italy and Denmark. Frequent co-authors include Larry Lo, Michael Davidson, Pablo E. Pérgola, Douglas Kling, Paul M. Ridker, G. Kees Hovingh, Dominic S. Raj, Peter Libby, Mads D.M. Engelmann and Milana Ivkovic. Their work appears in journals such as Journal of the American Society of Nephrology, Journal of Clinical Medicine, Nephrology Dialysis Transplantation, The Lancet and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.